Transcriptional Expressions of CXCL9/10/12/13 as Prognosis Factors in Breast Cancer

Identification of Therapeutic Targets and Prognostic Biomarkers Among CXC Chemokines in the Renal Cell Carcinoma Microenvironment

(2020) Qingquan Zeng et al.   Frontiers in Oncology

PARP Inhibitor Efficacy Depends on CD8+ T-cell Recruitment via Intratumoral STING Pathway Activation in BRCA-Deficient Models of Triple-Negative Breast Cancer

(2019) Constantia Pantelidou et al.   Cancer Discovery

The role of CXCL13 and CXCL9 in early breast cancer

(2019) Evangelia Razis et al.   Clinical Breast Cancer

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

(2018) Freddie Bray et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Functions of the CXC ligand family in the pancreatic tumor microenvironment

(2018) Nien-Hung Lee et al.   PANCREATOLOGY

CXC family of chemokines as prognostic or predictive biomarkers and possible drug targets in colorectal cancer

(2018) Sara Cabrero-de las Heras et al.   WORLD JOURNAL OF GASTROENTEROLOGY

GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses

(2017) Zefang Tang et al.   NUCLEIC ACIDS RESEARCH

Increasing Tumor-Infiltrating T Cells through Inhibition of CXCL12 with NOX-A12 Synergizes with PD-1 Blockade

(2017) Dirk Zboralski et al.   Cancer Immunology Research

UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses

(2017) Darshan S. Chandrashekar et al.   NEOPLASIA

Clinicopathological and Therapeutic Significance of CXCL12 Expression in Lung Cancer

(2017) H. Imai et al.   INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY

Ten-year survival in women with primary stage IV breast cancer

(2016) Lee Guek Eng et al.   BREAST CANCER RESEARCH AND TREATMENT

CXCL9 and CXCL10 predict survival and are regulated by cyclooxygenase inhibition in advanced serous ovarian cancer

(2016) Holger Bronger et al.   BRITISH JOURNAL OF CANCER

Expression and function of CXCL12/CXCR4/CXCR7 in thyroid cancer

(2016) XIAOLI ZHU et al.   INTERNATIONAL JOURNAL OF ONCOLOGY

Activation of STING-Dependent Innate Immune Signaling By S-Phase-Specific DNA Damage in Breast Cancer

(2016) Eileen E. Parkes et al.   JNCI-Journal of the National Cancer Institute

Pharmacological targeting of CXCL12/CXCR4 signaling in prostate cancer bone metastasis

(2016) M. Katie Conley-LaComb et al.   Molecular Cancer

Activation of STING-Dependent Innate Immune Signaling By S-Phase-Specific DNA Damage in Breast Cancer

(2016) Eileen E. Parkes et al.   JNCI-Journal of the National Cancer Institute

CXCL9: evidence and contradictions for its role in tumor progression

(2016) Qiang Ding et al.   Cancer Medicine

Hormone receptor-independent CXCL10 production is associated with the regulation of cellular factors linked to breast cancer progression and metastasis

(2015) Ahmed A. Ejaeidi et al.   EXPERIMENTAL AND MOLECULAR PATHOLOGY

Tissue injury and hypoxia promote malignant progression of prostate cancer by inducing CXCL13 expression in tumor myofibroblasts

(2014) M. Ammirante et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

A CXCL1 Paracrine Network Links Cancer Chemoresistance and Metastasis

(2012) Swarnali Acharyya et al.   CELL

Breast Cancer Stem Cells Are Regulated by Mesenchymal Stem Cells through Cytokine Networks

(2011) Suling Liu et al.   CANCER RESEARCH

CXCR3 in T cell function

(2011) Joanna R. Groom et al.   EXPERIMENTAL CELL RESEARCH

An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients

(2009) Balazs Györffy et al.   BREAST CANCER RESEARCH AND TREATMENT

Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources

(2009) Da Wei Huang et al.   Nature Protocols

The role of CXC chemokines and their receptors in cancer

(2008) Jo Vandercappellen et al.   CANCER LETTERS